// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Three-Year Kidney Transplant Experience at Garki Hospital, Abuja, Nigeria, 2013–2016.

M. Onuigbo - International Conference on Dialysis , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Mayo Clinic Thirteen-Year Retrospective Investigation of the Syndrome of Rapid Onset ESRD among Renal Transplant Recipients, 2001–2013

M. Onuigbo - International Conference on Dialysis , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

N/A

Intra-Operative Hypotension Is a Neglected But Preventable Causative Factor in Hospital-Acquired Acute Kidney Injury

M. Onuigbo - International Conference on Dialysis , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

A Rare Case of Persistently Recurrent Hyperkalemia in End Stage Renal Disease (ESRD) following Bio prosthetic Aortic Valve Replacement – Could the New Potassium-Binding Polymer, Patiromer, Have Been Useful Here?

M. Onuigbo - International Conference on Dialysis , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

Adenosine

A Rare Complication of Transurethral Foley Catheterization Misplacement Producing Distal Right Ipsilateral Ureteric Obstruction, Contralateral Left Ureteric Obstruction and Acute Kidney Injury

M. Onuigbo - International Conference on Dialysis , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

Levofloxacin

A case series examining the safety and efficacy of anticoagulation management in pregnant women with metallic heart valves

K. White - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

A collaborative study to harmonize thrombin generation assays for measurement of procoagulant activity in immune globulins

M. Shea - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Evithrom

A comparison of thrombin generation ex vivo circuit and in critically ill patients requiring Extracorporeal Membrane Oxygenation

A. Doyle - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Evithrom

A microfluidic model to study the initiation of venous thrombosis

L. Mereweather - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A near real-time surveillance algorithm to identify in-hospital VITT cases

S. Williams - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A new mouse model of impaired fibrin α-chain crosslinking shows increased venous thrombembolism

C. Duval - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary embolism

Glutamine

A Novel Assay to Investigate Thrombogenesis in TTP Patients

A. Constantinescu-Bercu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

A novel homozygous KLKB1 missense variant causative of severe Prekallikrein deficiency.

M. Mitchell - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sjogren's syndrome

N/A

A novel prothrombin R533Q variant in patient with recurrent venous thrombosis

C. Van Laer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary embolism

Evithrom

A Phase 3 study (ATLAS-PPX) to evaluate efficacy and safety of fitusiran, an siRNA therapeutic, in people with haemophilia A or B who have switched from prior factor or bypassing agent prophylaxis

G. Kenet - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

A pilot, open-label, phase II clinical trial of nebulised recombinant tissue-plasminogen activator in patients with COVID-19 acute respiratory distress syndrome: the PACA trial

P. Chowdary - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute lung injury

Fibrinogen (IV)

A potential suitable alternative to Triton-X-100 for use in sample preparation for platelet nucleotide analysis

A. McCormick - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A re-visit of the Pre-Kallikrein (Fletcher trait) assay to optimise for laboratory use

A. McCormick - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Fletcher factor deficiency

Calcium Chloride

A Systematic Review of Acquired von Willebrand Syndrome Associated With Cardiac Disorders: Epidemiology, Disease Burden, and Management

P. Du - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Systematic Review of Acquired von Willebrand Syndrome Associated With Non-Cardiac Diseases: Epidemiology, Disease Burden, and Management

P. Du - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved